The importance of lipid spectrum changes in women with polycystic ovary syndrome(PCOS)
Autor: | Frysak Z, Sarapatka J, Sarapatkova H |
---|---|
Rok vydání: | 2014 |
Předmět: |
Blood lipoprotein
Adult Economics and Econometrics medicine.medical_specialty Waist endocrine system diseases Blood lipids Body Mass Index chemistry.chemical_compound Young Adult Internal medicine Healthy control Materials Chemistry Media Technology medicine Humans Cholesterol business.industry Waist-Hip Ratio Polycystic ovary syndrome (PCOS) nutritional and metabolic diseases Forestry Anthropometry medicine.disease Lipids female genital diseases and pregnancy complications Endocrinology chemistry Case-Control Studies lipids (amino acids peptides and proteins) Female business Body mass index Polycystic Ovary Syndrome |
Zdroj: | Bratislavske lekarske listy. 115(9) |
ISSN: | 0006-9248 |
Popis: | AIM of the study was to compare levels of blood lipids, anthropometric characteristics and their relationship in women with PCOS with a group of healthy women. METHODS AND RESULTS We determined anthropometric indicators (BMI - body mass index, waist measurement, waist/hip ratio), blood lipid levels (total cholesterol TCH, high density cholesterol HDL, low density cholesterol LDL and triglycerides TAG) in a group of women with PCOS and a healthy control group. Levels of evaluated blood lipids in women with PCOS and the healthy control group were within the normal range. Women with PCOS differed statistically significantly from the control group in a higher concentration of triglycerides (control 1.01 ± 0.7 mmol.l-1, PCOS 1.17 ± 0.58). In women with PCOS we proved a positive correlation between BMI, total cholesterol, LDL cholesterol and levels of triglycerides. In women with PCOS waist measurement showed a statistically significant relationship to values of LDL cholesterol, HDL cholesterol and level of triglycerides. CONCLUSIONS All women with PCOS in our study had very good levels of blood lipoproteins (total cholesterol, LDL and HDL cholesterol, triglycerides) so we are not sure if there is any importance of changes in blood lipid metabolism in these patients (Tab. 1, Fig. 2, Ref. 16). |
Databáze: | OpenAIRE |
Externí odkaz: |